On ECHEMI
Home > Drugs > Astrocytoma
Astrocytoma
Astrocytic tumors refer to tumors composed of astrocytes and are the most common neuroepithelial tumors. They are divided into grades I to IV. Grade I tumors mostly grow in the white matter of the brain in adults and are divided into two types: protoplasmic and fibrous. Grade II tumors are poorly differentiated astrocytomas, or astrocytomas. The course of these two types of diseases progresses slowly. Grade III to IV astrocytomas are glioblastoma multiforme, which are highly malignant and common after middle age. Astrocytomas can occur in any part of the central nervous system. Generally, they are more common in the brain in adults and in the subtentorial part in children. It has been reported that 3/4 of them are supratentorial and 1/4 are infratentorial. Those that occur supratentorially are more common in the frontal and temporal lobes, followed by the parietal lobe, and less common in the occipital lobe. The tumor can involve more than two lobes of the brain. It can also be seen beside the optic nerve, thalamus and third ventricle, while those infratentorially are mostly located in the cerebellar hemispheres and fourth ventricle, and can also be seen in the cerebellar vermis and brainstem.
Related Drugs
CARMUSTINE- carmustine
Indication: Carmustine for Injection is a nitrosourea indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in the following: Brain tumors glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors (1) Multiple myeloma-in combination with prednisone (1) Relapsed or refractory Hodgkin's lymphoma in combination with other approved drugs (1) Relapsed or refractory Non-Hodgkin's lymphomas in combination with other approved drugs (1) Carmustine for injection is indicated as palliative therapy as a single agent or in established combination therapy in the following: Brain tumors glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors. Multiple myeloma in combination with prednisone. Relapsed or refractory Hodgkin's lymphoma in combination with other approved drugs. Relapsed or refractory Non-Hodgkin's lymphomas in combination with other approved drugs.
Manufacturer:

STI Pharma LLC

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.